Breast Cancer Symposium Saturday

San Francisco, CA - Breast Cancer Symposium 2012: Stephen E. Jones, MD discusses Debate: Use of Anthracyclines in HER2-Positive and HER2-Negative Patients: Con during the General Session XI: Debates on Current Controversies in Systemic Therapy at the Breast Cancer Symposium 2012 here today, Saturday September 15, 2012. The Symposium is supported by ASCO, the American Society of Clinical Oncology, ASTRO, The American Society of Radiation Oncology, SSO, Society of Surgical Oncology, ASBS American Society of Breast Surgeons and ASBC American Society of Breast Cancer. Over 1,000 physicians, researchers and allied healthcare professionals are attending the meeting which is being held at the San Francisco Marriott and features the latest Breast Cancer research in the areas of basic and clinical science. Photo by © ASCO/Todd Buchanan 2012 Technical Questions: todd@toddbuchanan.com;